InvestorsHub Logo
Followers 12
Posts 743
Boards Moderated 0
Alias Born 04/14/2011

Re: Aqua post# 45541

Thursday, 02/14/2013 5:49:04 PM

Thursday, February 14, 2013 5:49:04 PM

Post# of 403253
I really like this quote from JT. Especially the part about scaling up for trials. this is more than I thought he would say as previously he said we wouldn't hear anything more until the trials were over or a partner for an ART product was named. "all in all, it was another excellent quarter of progress for Elite"


Jerry Treppel, Chairman and CEO of Elite commented, "The Company continues to progress towards its goal of becoming break-even on an operating cash flow basis exclusive of any clinical trials required for our abuse-resistant opioid products. We expect this to occur in the next quarter or two. We are in the process of finalizing and scaling up the formulation of one of our abuse-resistant opioid products so as to commence human trials. As we have stated before, we are in the process of seeking additional capital to finance these trials. All in all, it was another excellent quarter of progress for Elite."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News